Vaccination with VRP-TRP2 was more effective than combination of VRP-gp100 and VRP-tyr, and the efficacy of the combination of all three VRP expressing the different melanoma antigens was not significantly better than VRP-TRP2 alone (Figure 1B). The gene discussed is DCT; the disease is melanoma.